BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hashempoor T, Alborzi AM, Moayedi J, Ajorloo M, Bamdad T, Sharifi AH, Lavergne JP, Haj-sheykholeslami A, Merat S. A Decline in Anti-Core+1 Antibody Titer Occurs in Successful Treatment of Patients Infected with Hepatitis C Virus. Jundishapur J Microbiol 2018;11. [DOI: 10.5812/jjm.58294] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Mohamadi M, Azarbayjani K, Mozhgani SH, Bamdad T, Alamdary A, Nikoo HR, Hashempour T, Hedayat Yaghoobi M, Ajorloo M. Hepatitis C virus alternative reading frame protein (ARFP): Production, features, and pathogenesis. J Med Virol 2020. [PMID: 32470157 DOI: 10.1002/jmv.26091] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Musavi Z, Hashempour T, Moayedi J, Dehghani B, Ghassabi F, Hallaji M, Hosseini SY, Yaghoubi R, Gholami S, Dehyadegari MA, Merat S. Antibody Development to HCV Alternate Reading Frame Protein in Liver Transplant Candidate and its Computational Analysis. CP 2020;17:154-70. [DOI: 10.2174/1570164617666190822103329] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
3 Dehghani B, Dehghani A, Sarvari J. Knowledge and Awareness Regarding Hepatitis B, Hepatitis C, and Human Immunodeficiency Viruses Among College Students: A Report From Iran. Int Q Community Health Educ 2020;41:15-23. [PMID: 31876257 DOI: 10.1177/0272684X19896727] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
4 Hashempour T, Dehghani B, Mousavi Z, Yahaghi M, Hasanshahi Z, Moayedi J, Akbari T, Davarpanah MA. Evaluating Drug Resistant Mutations to HCV NS3 Protease Inhibitors in Iranian Naïve Patients. Int J Pept Res Ther 2020;26:1699-710. [DOI: 10.1007/s10989-019-09957-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]